{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:31:12Z","timestamp":1791858672973,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P50 CA217694"],"award-info":[{"award-number":["P50 CA217694"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P50 CA 140146-01"],"award-info":[{"award-number":["P50 CA 140146-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P50 CA217694"],"award-info":[{"award-number":["P50 CA217694"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P50 CA 140146-01"],"award-info":[{"award-number":["P50 CA 140146-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P50 CA217694"],"award-info":[{"award-number":["P50 CA217694"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"DOI":"10.13039\/100000092","name":"U.S. Department of Health & Human Services | NIH | U.S. National Library of Medicine","doi-asserted-by":"publisher","award":["P50 CA 140146-01"],"award-info":[{"award-number":["P50 CA 140146-01"]}],"id":[{"id":"10.13039\/100000092","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1038\/s41379-022-01107-6","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T02:04:02Z","timestamp":1654567442000},"page":"1644-1655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Myxoid pleomorphic liposarcoma is distinguished from other liposarcomas by widespread loss of heterozygosity and significantly worse overall survival: a genomic and clinicopathologic study"],"prefix":"10.1016","volume":"35","author":[{"given":"Josephine K.","family":"Dermawan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinchun","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0724-8263","authenticated-orcid":false,"given":"Leonard","family":"Wexler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Tap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8114-0237","authenticated-orcid":false,"given":"Chad M.","family":"Vanderbilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9717-8205","authenticated-orcid":false,"given":"Cristina R.","family":"Antonescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-022-01107-6_bib1","doi-asserted-by":"crossref","unstructured":"Alaggio R., Coffin C.M., Weiss S.W., Bridge J.A., Issakov J., Oliveira A.M. & Folpe A.L. Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age. Am. J. Surg. Pathol. 33, 645-\u2013658 (2009).","DOI":"10.1097\/PAS.0b013e3181963c9c"},{"key":"10.1038\/s41379-022-01107-6_bib2","doi-asserted-by":"crossref","unstructured":"Boland J.M., Colby T.V. & Folpe A.L. Liposarcomas of the mediastinum and thorax: a clinicopathologic and molecular cytogenetic study of 24 cases, emphasizing unusual and diverse histologic features. Am. J. Surg. Pathol. 36, 1395\u20131403 (2012).","DOI":"10.1097\/PAS.0b013e3182562bc1"},{"key":"10.1038\/s41379-022-01107-6_bib3","doi-asserted-by":"crossref","unstructured":"Creytens D., Folpe A.L., Koelsche C., Mentzel T., Ferdinande L., van Gorp J.M., et al. Myxoid pleomorphic liposarcoma-a clinicopathologic, immunohistochemical, molecular genetic and epigenetic study of 12 cases, suggesting a possible relationship with conventional pleomorphic liposarcoma. Mod. Pathol. 34, 2043\u20132049 (2021).","DOI":"10.1038\/s41379-021-00862-2"},{"key":"10.1038\/s41379-022-01107-6_bib4","doi-asserted-by":"crossref","unstructured":"Creytens D., van Gorp J., Ferdinande L., Van Roy N. & Libbrecht L. Array-based comparative genomic hybridization analysis of a pleomorphic myxoid liposarcoma. J. Clin. Pathol. 67, 834\u2013835 (2014).","DOI":"10.1136\/jclinpath-2014-202420"},{"key":"10.1038\/s41379-022-01107-6_bib5","doi-asserted-by":"crossref","unstructured":"Hofvander J., Jo V.Y., Ghanei I., Gisselsson D., M\u00e5rtensson E. & Mertens F. Comprehensive genetic analysis of a paediatric pleomorphic myxoid liposarcoma reveals near-haploidization and loss of the RB1 gene. Histopathology. 69, 141\u2013147 (2016).","DOI":"10.1111\/his.12913"},{"key":"10.1038\/s41379-022-01107-6_bib6","doi-asserted-by":"crossref","unstructured":"Cheng D.T., Mitchell T.N., Zehir A., Shah R.H., Benayed R., Syed A., et al. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. J. Mol. Diagn. 17, 251\u2013264 (2015).","DOI":"10.1016\/j.jmoldx.2014.12.006"},{"key":"10.1038\/s41379-022-01107-6_bib7","doi-asserted-by":"crossref","unstructured":"Mayakonda A., Lin D., Assenov Y., Plass C. & Koeffler P.H. \u201cMaftools: efficient and comprehensive analysis of somatic variants in cancer.\u201d Genome Res. 28, 1747\u20131756 (2018).","DOI":"10.1101\/gr.239244.118"},{"key":"10.1038\/s41379-022-01107-6_bib8","unstructured":"Zhang J. (2021). CNTools: Convert segment data into a region by sample matrix to allow for other high level computational analyses. R package version 1.50.0."},{"key":"10.1038\/s41379-022-01107-6_bib9","doi-asserted-by":"crossref","first-page":"e1009557","DOI":"10.1371\/journal.pgen.1009557","article-title":"Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes","volume":"17","author":"Wang","year":"2021","journal-title":"PLoS Genet"},{"key":"10.1038\/s41379-022-01107-6_bib10","doi-asserted-by":"crossref","unstructured":"Gu, Z. Circlize implements and enhances circular visualization in R. Bioinformatics. 30, 2811\u20132812 (2014).","DOI":"10.1093\/bioinformatics\/btu393"},{"key":"10.1038\/s41379-022-01107-6_bib11","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1093\/nar\/gkw520","article-title":"FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing","volume":"44","author":"Shen","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/s41379-022-01107-6_bib12","doi-asserted-by":"crossref","unstructured":"Plukker, J.T., Joosten, H.J., Rensing, J.B. & Van Haelst U.J. Primary liposarcoma of the mediastinum in a child. J. Surg. Oncol. 37, 257\u2013263 (1988).","DOI":"10.1002\/jso.2930370410"},{"key":"10.1038\/s41379-022-01107-6_bib13","doi-asserted-by":"crossref","unstructured":"Greif J., Marmor S., Merimsky O., Kovner F. & Inbar M. Primary liposarcoma of the mediastinum. Sarcoma. 2, 205\u2013257 (1998).","DOI":"10.1080\/13577149877993"},{"key":"10.1038\/s41379-022-01107-6_bib14","doi-asserted-by":"crossref","unstructured":"Hahn H.P. & Fletcher C.D. Primary mediastinal liposarcoma: clinicopathologic analysis of 24 cases. Am. J. Surg. Pathol. 31, 1868\u20131874 (2007).","DOI":"10.1097\/PAS.0b013e318093f925"},{"key":"10.1038\/s41379-022-01107-6_bib15","doi-asserted-by":"crossref","unstructured":"von Mehren M., Randall R.L., Benjamin R.S., Boles S., Bui M.M., Ganjoo K.N., et al. Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc. Netw. 16, 536\u2013563 (2018).","DOI":"10.6004\/jnccn.2018.0025"},{"key":"10.1038\/s41379-022-01107-6_bib16","unstructured":"Gronchi A., Miah A.B., Dei Tos A.P., Abecassis N., Bajpai J., Bauer S., Biagini R., et al. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 32, 1348\u20131365 (2021)."},{"key":"10.1038\/s41379-022-01107-6_bib17","doi-asserted-by":"crossref","unstructured":"Bode-Lesniewska B., Frigerio S., Exner U., Abdou M.T, Moch H. & Zimmermann DR. Relevance of translocation type in myxoid liposarcoma and identification of a novel EWSR1-DDIT3 fusion. Genes Chromosomes Cancer. 46, 961\u2013971 (2007).","DOI":"10.1002\/gcc.20478"},{"key":"10.1038\/s41379-022-01107-6_bib18","doi-asserted-by":"crossref","unstructured":"Hornick J.L., Bosenberg M.W., Mentzel T., McMenamin M.E., Oliveira A.M. & Fletcher C.D. Pleomorphic liposarcoma: clinicopathologic analysis of 57 cases. Am. J. Surg. Pathol. 28, 1257\u20131267 (2004).","DOI":"10.1097\/01.pas.0000135524.73447.4a"},{"key":"10.1038\/s41379-022-01107-6_bib19","doi-asserted-by":"crossref","unstructured":"Koelsche C., Renner M., Hartmann W., Brandt R., Lehner B., Waldburger N., et al. TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities. J. Exp. Clin. Cancer Res. 33, 33 (2014).","DOI":"10.1186\/1756-9966-33-33"},{"key":"10.1038\/s41379-022-01107-6_bib20","unstructured":"Barretina J., Taylor B.S., Banerji S., Ramos A.H., Lagos-Quintana M., Decarolis P.L., et al. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nat. Genet. 42, 715\u2013721 (2010)."},{"key":"10.1038\/s41379-022-01107-6_bib21","doi-asserted-by":"crossref","unstructured":"Demicco E.G., Torres K.E., Ghadimi M.P., Colombo C., Bolshakov S., Hoffman A., et al. Involvement of the PI3K\/Akt pathway in myxoid\/round cell liposarcoma. Mod. Pathol. 25, 212\u2013221 (2012).","DOI":"10.1038\/modpathol.2011.148"},{"key":"10.1038\/s41379-022-01107-6_bib22","doi-asserted-by":"crossref","unstructured":"Trautmann M., Cyra M., Isfort I., Jeiler B., Kr\u00fcger A., Gr\u00fcnewald I., et al. Phosphatidylinositol-3-kinase (PI3K)\/Akt Signaling is Functionally Essential in Myxoid Liposarcoma. Mol. Cancer Ther. 18, 834\u2013844 (2019).","DOI":"10.1158\/1535-7163.MCT-18-0763"},{"key":"10.1038\/s41379-022-01107-6_bib23","doi-asserted-by":"crossref","unstructured":"Ghadimi M.P., Liu P., Peng T., Bolshakov S., Young E.D., Torres K.E., et al. Pleomorphic liposarcoma: clinical observations and molecular variables. Cancer. 117, 5359\u20135369 (2011).","DOI":"10.1002\/cncr.26195"},{"key":"10.1038\/s41379-022-01107-6_bib24","doi-asserted-by":"crossref","unstructured":"Sinclair T.J., Thorson CM., Alvarez E., Tan S., Spunt S.L. & Chao S.D. Pleomorphic myxoid liposarcoma in an adolescent with Li-Fraumeni syndrome. Pediatr. Surg. Int. 33, 631\u2013635 (2017).","DOI":"10.1007\/s00383-017-4063-x"},{"key":"10.1038\/s41379-022-01107-6_bib25","doi-asserted-by":"crossref","unstructured":"Yoshikawa Y., Emi M., Hashimoto-Tamaoki T., Ohmuraya M., Sato A., Tsujimura T., et al. High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma. Proc. Natl. Acad. Sci. U. S. A. 113, 13432\u201313437 (2016).","DOI":"10.1073\/pnas.1612074113"},{"key":"10.1038\/s41379-022-01107-6_bib26","doi-asserted-by":"crossref","unstructured":"Dal Cin P., Sciot R., Fletcher C.D., Samson I., De Vos R., Mandahl N., et al. Inflammatory leiomyosarcoma may be characterized by specific near-haploid chromosome changes. J. Pathol. 185, 112\u2013115 (1998).","DOI":"10.1002\/(SICI)1096-9896(199805)185:1<112::AID-PATH54>3.3.CO;2-L"},{"key":"10.1038\/s41379-022-01107-6_bib27","doi-asserted-by":"crossref","unstructured":"Arbajian E., K\u00f6ster J., Vult von Steyern F. & Mertens F. Inflammatory leiomyosarcoma is a distinct tumor characterized by near-haploidization, few somatic mutations, and a primitive myogenic gene expression signature. Mod. Pathol. 31, 93\u2013100 (2018).","DOI":"10.1038\/modpathol.2017.113"},{"key":"10.1038\/s41379-022-01107-6_bib28","doi-asserted-by":"crossref","unstructured":"Cloutier J.M., Charville G.W., Mertens F., Sukov W., Fritchie K., Perry K.D., et al. \u201cInflammatory Leiomyosarcoma\u201d and \u201cHistiocyte-rich Rhabdomyoblastic Tumor\u201d: a clinicopathological, immunohistochemical and genetic study of 13 cases, with a proposal for reclassification as \u201cInflammatory Rhabdomyoblastic Tumor\u201d. Mod Pathol. 34, 758\u2013769 (2021).","DOI":"10.1038\/s41379-020-00703-8"},{"key":"10.1038\/s41379-022-01107-6_bib29","doi-asserted-by":"crossref","unstructured":"Bielski C.M., Zehir A., Penson A.V., Donoghue M.T.A., Chatila W., Armenia J., et al. Genome doubling shapes the evolution and prognosis of advanced cancers. Nat. Genet. 50, 1189\u20131195 (2018).","DOI":"10.1038\/s41588-018-0165-1"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01107-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01107-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222002319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222002319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01107-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:36:07Z","timestamp":1760229367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222002319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0893395222002319"],"URL":"https:\/\/doi.org\/10.1038\/s41379-022-01107-6","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myxoid pleomorphic liposarcoma is distinguished from other liposarcomas by widespread loss of heterozygosity and significantly worse overall survival: a genomic and clinicopathologic study","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-022-01107-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}